• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.硫酸乙酰肝素结合对重组腺相关病毒载体转导视网膜的影响
J Virol. 2016 Mar 28;90(8):4215-4231. doi: 10.1128/JVI.00200-16. Print 2016 Apr.
2
Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.硫酸乙酰肝素结合促进玻璃体内递送的腺相关病毒载体在视网膜的积累以增强转导,但对嗜性影响较弱。
J Virol. 2016 Oct 14;90(21):9878-9888. doi: 10.1128/JVI.01568-16. Print 2016 Nov 1.
3
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.通过使用新型、衣壳突变的 AAV 载体经玻璃体腔递送来靶向感光细胞。
PLoS One. 2013 Apr 26;8(4):e62097. doi: 10.1371/journal.pone.0062097. Print 2013.
4
Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach.用于通过视网膜下或玻璃体内途径将基因递送至犬视网膜的酪氨酸衣壳突变型腺相关病毒载体。
Gene Ther. 2014 Jan;21(1):96-105. doi: 10.1038/gt.2013.64. Epub 2013 Nov 14.
5
Evaluation of Photoreceptor Transduction Efficacy of Capsid-Modified Adeno-Associated Viral Vectors Following Intravitreal and Subretinal Delivery in Sheep.评估经玻璃体内和视网膜下递送至绵羊后,衣壳修饰的腺相关病毒载体对光感受器转导效率的影响。
Hum Gene Ther. 2020 Jul;31(13-14):719-729. doi: 10.1089/hum.2020.023. Epub 2020 Jul 6.
6
SubILM Injection of AAV for Gene Delivery to the Retina.用于视网膜基因递送的腺相关病毒亚内界膜注射
Methods Mol Biol. 2019;1950:249-262. doi: 10.1007/978-1-4939-9139-6_14.
7
Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.腺相关病毒介导的小鼠视网膜病毒转导:病毒衣壳和基因组大小的影响
J Virol. 2002 Aug;76(15):7651-60. doi: 10.1128/jvi.76.15.7651-7660.2002.
8
Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.表面蛋白的交换对病毒载体的细胞特异性和转导特性有影响:以视网膜为模型。
Hum Mol Genet. 2001 Dec 15;10(26):3075-81. doi: 10.1093/hmg/10.26.3075.
9
Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors.通过使用组合性rAAV2衣壳突变载体经玻璃体内注射改善小鼠和人类视网膜中的光感受器靶向性
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6429-6439. doi: 10.1167/iovs.17-22281.
10
Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.视网膜下注射AAV5载体后的基因治疗不受对侧眼先前玻璃体内注射AAV5载体的影响。
Mol Vis. 2009;15:267-75. Epub 2009 Feb 6.

引用本文的文献

1
Gene therapy for geographic atrophy in age-related macular degeneration: current insights.年龄相关性黄斑变性地图状萎缩的基因治疗:当前见解
Eye (Lond). 2025 Feb;39(2):274-283. doi: 10.1038/s41433-024-03463-w. Epub 2024 Nov 22.
2
Recombinant adeno-associated virus as a delivery platform for ocular gene therapy: A comprehensive review.重组腺相关病毒作为眼部基因治疗的递送平台:综述
Mol Ther. 2024 Dec 4;32(12):4185-4207. doi: 10.1016/j.ymthe.2024.10.017. Epub 2024 Oct 28.
3
Engineered AAV capsid transport mutants overcome transduction deficiencies in the aged CNS.工程化腺相关病毒衣壳转运突变体克服了衰老中枢神经系统中的转导缺陷。
Mol Ther Nucleic Acids. 2024 Sep 12;35(4):102332. doi: 10.1016/j.omtn.2024.102332. eCollection 2024 Dec 10.
4
Retinal Penetrating Adeno-Associated Virus.视网膜穿透性腺相关病毒。
Invest Ophthalmol Vis Sci. 2024 Aug 1;65(10):30. doi: 10.1167/iovs.65.10.30.
5
[Upregulating KLF11 ameliorates intestinal inflammation in mice with 2, 4, 6-trinitrobenesulfonic acid-induced colitis by inhibiting the JAK2/STAT3 signaling pathway].上调KLF11通过抑制JAK2/STAT3信号通路改善2,4,6-三硝基苯磺酸诱导的小鼠结肠炎
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Apr 20;44(4):765-772. doi: 10.12122/j.issn.1673-4254.2024.04.19.
6
Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasion.在非人灵长类动物中玻璃体内注射合理设计的腺相关病毒衣壳文库,可鉴定出具有增强视网膜转导能力和逃避中和抗体能力的变体。
Mol Ther. 2023 Dec 6;31(12):3441-3456. doi: 10.1016/j.ymthe.2023.10.001. Epub 2023 Oct 9.
7
Immunobiology of a rationally-designed AAV2 capsid following intravitreal delivery in mice.经玻璃体内递送后,一种经合理设计的 AAV2 衣壳的免疫生物学特性。
Gene Ther. 2023 Sep;30(9):723-735. doi: 10.1038/s41434-023-00409-x. Epub 2023 Jun 29.
8
Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?基于腺相关病毒(AAV)的视网膜疾病基因疗法:我们目前的进展如何?
Appl Clin Genet. 2023 May 30;16:111-130. doi: 10.2147/TACG.S383453. eCollection 2023.
9
Bruch's Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration.布鲁赫膜:年龄相关性黄斑变性基于补体疗法的关键考量因素
J Clin Med. 2023 Apr 14;12(8):2870. doi: 10.3390/jcm12082870.
10
Ocular Delivery of Therapeutic Proteins: A Review.治疗性蛋白质的眼部给药:综述
Pharmaceutics. 2023 Jan 6;15(1):205. doi: 10.3390/pharmaceutics15010205.

本文引用的文献

1
Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs.在犬类中使用玻璃体内注射腺相关病毒(AAV)载体进行光感受器靶向基因递送。
Gene Ther. 2016 Apr;23(4):400. doi: 10.1038/gt.2016.10.
2
The structure of AAVrh32.33, a novel gene delivery vector.新型基因递送载体AAVrh32.33的结构
J Struct Biol. 2014 May;186(2):308-17. doi: 10.1016/j.jsb.2014.03.020. Epub 2014 Apr 2.
3
Structural insights into adeno-associated virus serotype 5.腺相关病毒血清型 5 的结构见解。
J Virol. 2013 Oct;87(20):11187-99. doi: 10.1128/JVI.00867-13. Epub 2013 Aug 7.
4
Overcoming preexisting humoral immunity to AAV using capsid decoys.利用衣壳诱饵克服 AAV 的预先存在的体液免疫。
Sci Transl Med. 2013 Jul 17;5(194):194ra92. doi: 10.1126/scitranslmed.3005795.
5
In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous.玻璃体腔给药治疗性外层视网膜的新型腺相关病毒的活体定向进化。
Sci Transl Med. 2013 Jun 12;5(189):189ra76. doi: 10.1126/scitranslmed.3005708.
6
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.通过使用新型、衣壳突变的 AAV 载体经玻璃体腔递送来靶向感光细胞。
PLoS One. 2013 Apr 26;8(4):e62097. doi: 10.1371/journal.pone.0062097. Print 2013.
7
Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?优化重组腺相关病毒 2(AAV2)载体的衣壳:最后的门槛?
PLoS One. 2013;8(3):e59142. doi: 10.1371/journal.pone.0059142. Epub 2013 Mar 19.
8
AAV9 targets cone photoreceptors in the nonhuman primate retina.腺相关病毒 9 可靶向非人灵长类动物视网膜中的锥形光感受器。
PLoS One. 2013;8(1):e53463. doi: 10.1371/journal.pone.0053463. Epub 2013 Jan 30.
9
A comprehensive review of retinal gene therapy.视网膜基因治疗的全面综述。
Mol Ther. 2013 Mar;21(3):509-19. doi: 10.1038/mt.2012.280. Epub 2013 Jan 29.
10
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.工程化 AAV 载体最大限度地减少了衣壳特异性 CD8+ T 细胞对转导肝细胞的体内靶向作用。
Blood. 2013 Mar 21;121(12):2224-33. doi: 10.1182/blood-2012-10-460733. Epub 2013 Jan 16.

硫酸乙酰肝素结合对重组腺相关病毒载体转导视网膜的影响

Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.

作者信息

Boye Sanford L, Bennett Antonette, Scalabrino Miranda L, McCullough K Tyler, Van Vliet Kim, Choudhury Shreyasi, Ruan Qing, Peterson James, Agbandje-McKenna Mavis, Boye Shannon E

机构信息

Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA.

Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida, USA.

出版信息

J Virol. 2016 Mar 28;90(8):4215-4231. doi: 10.1128/JVI.00200-16. Print 2016 Apr.

DOI:10.1128/JVI.00200-16
PMID:26865709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4810560/
Abstract

UNLABELLED

Adeno-associated viruses (AAVs) currently are being developed to efficiently transduce the retina following noninvasive, intravitreal (Ivt) injection. However, a major barrier encountered by intravitreally delivered AAVs is the inner limiting membrane (ILM), a basement membrane rich in heparan sulfate (HS) proteoglycan. The goal of this study was to determine the impact of HS binding on retinal transduction by Ivt-delivered AAVs. The heparin affinities of AAV2-based tyrosine-to-phenylalanine (Y-F) and threonine-to-valine (T-V) capsid mutants, designed to avoid proteasomal degradation during cellular trafficking, were established. In addition, the impact of grafting HS binding residues onto AAV1, AAV5, and AAV8(Y733F) as well as ablation of HS binding by AAV2-based vectors on retinal transduction was investigated. Finally, the potential relationship between thermal stability of AAV2-based capsids and Ivt-mediated transduction was explored. The results show that the Y-F and T-V AAV2 capsid mutants bind heparin but with slightly reduced affinity relative to that of AAV2. The grafting of HS binding increased Ivt transduction by AAV1 but not by AAV5 or AAV8(Y733F). The substitution of any canonical HS binding residues ablated Ivt-mediated transduction by AAV2-based vectors. However, these same HS variant vectors displayed efficient retinal transduction when delivered subretinally. Notably, a variant devoid of canonical HS binding residues, AAV2(4pMut)ΔHS, was remarkably efficient at transducing photoreceptors. The disparate AAV phenotypes indicate that HS binding, while critical for AAV2-based vectors, is not the sole determinant for transduction via the Ivt route. Finally, Y-F and T-V mutations alter capsid stability, with a potential relationship existing between stability and improvements in retinal transduction by Ivt injection.

IMPORTANCE

AAV has emerged as the vector of choice for gene delivery to the retina, with attention focused on developing vectors that can mediate transduction following noninvasive, intravitreal injection. HS binding has been postulated to play a role in intravitreally mediated transduction of retina. Our evaluation of the HS binding of AAV2-based variants and other AAV serotype vectors and the correlation of this property with transduction points to HS affinity as a factor controlling retinal transduction following Ivt delivery. However, HS binding is not the only requirement for improved Ivt-mediated transduction. We show that AAV2-based vectors lacking heparin binding transduce retina by subretinal injection and display a remarkable ability to transduce photoreceptors, indicating that other receptors are involved in this phenotype.

摘要

未标记

目前正在研发腺相关病毒(AAV),以便在进行非侵入性玻璃体内(Ivt)注射后有效地转导视网膜。然而,玻璃体内递送的AAV遇到的一个主要障碍是内界膜(ILM),这是一种富含硫酸乙酰肝素(HS)蛋白聚糖的基底膜。本研究的目的是确定HS结合对Ivt递送的AAV视网膜转导的影响。建立了基于AAV2的酪氨酸到苯丙氨酸(Y-F)和苏氨酸到缬氨酸(T-V)衣壳突变体的肝素亲和力,这些突变体旨在避免细胞运输过程中的蛋白酶体降解。此外,还研究了将HS结合残基嫁接到AAV1、AAV5和AAV8(Y733F)上以及基于AAV2的载体消除HS结合对视网膜转导的影响。最后,探讨了基于AAV2的衣壳热稳定性与Ivt介导的转导之间的潜在关系。结果表明,Y-F和T-V AAV2衣壳突变体与肝素结合,但亲和力相对于AAV2略有降低。HS结合的嫁接增加了AAV1的Ivt转导,但没有增加AAV5或AAV8(Y733F)的Ivt转导。任何典型HS结合残基的取代都消除了基于AAV2的载体的Ivt介导的转导。然而,当通过视网膜下递送时,这些相同的HS变体载体显示出有效的视网膜转导。值得注意的是,一种缺乏典型HS结合残基的变体AAV2(4pMut)ΔHS在转导光感受器方面非常有效。不同的AAV表型表明,HS结合虽然对基于AAV2的载体至关重要,但不是通过Ivt途径进行转导的唯一决定因素。最后,Y-F和T-V突变改变了衣壳稳定性,稳定性与Ivt注射后视网膜转导的改善之间存在潜在关系。

重要性

AAV已成为向视网膜进行基因递送的首选载体,注意力集中在开发能够在非侵入性玻璃体内注射后介导转导的载体。据推测,HS结合在玻璃体内介导的视网膜转导中起作用。我们对基于AAV2的变体和其他AAV血清型载体的HS结合及其与转导的相关性的评估表明,HS亲和力是控制Ivt递送后视网膜转导的一个因素。然而,HS结合并不是改善Ivt介导的转导的唯一要求。我们表明,缺乏肝素结合的基于AAV2的载体通过视网膜下注射转导视网膜,并显示出转导光感受器的显著能力,表明其他受体参与了这种表型。